Does low-dose spironolactone increase cardiovascular protection in patients with chronic kidney disease? [PDF]
García-Carro C, Sarafidis P.
europepmc +1 more source
Muscle strength, Na,K‐pumps, magnesium and potassium in patients with alcoholic liver cirrhosis – relation to spironolactone [PDF]
Niels Kristian Aagaard+5 more
openalex +1 more source
Renal clearance estimated by rubidium-82 positron emission tomography/computed tomography and technetium-99m-mercaptoacetyltriglycine clearance infusion technique. [PDF]
Langaa SS+7 more
europepmc +1 more source
Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide [PDF]
Yoshitaka Hayashi+3 more
openalex +1 more source
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants. [PDF]
Soliman A+5 more
europepmc +1 more source
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress [PDF]
Agostino Virdis+5 more
openalex +1 more source
Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice. [PDF]
Alfarano M+10 more
europepmc +1 more source
PCD12: SPIRONOLACTONE IN HEART FAILURE: LIFE AND COST SAVING TREATMENT IN POLAND
J Kuźniar+2 more
openalex +1 more source